ClinicalTrials.Veeva

Menu

Association Study of Gene Polymorphisms With Cardiac Performance

U

University Hospital Essen

Status

Unknown

Conditions

Coronary Artery Disease
Genetic Polymorphism
Hemodynamics

Study type

Observational

Funder types

Other

Identifiers

NCT00730899
HOT-001

Details and patient eligibility

About

The purpose of this study is to determine whether polymorphisms in G protein subunits, namely Galphas and Galphaq, are associated with altered cardiac performance in heart failure patients.

Full description

G Protein pathways plays a pivotal role in mediating positive inotropy and cardiac hypertrophy by transducing signals of neurohormones in cardiomyocytes. Single nucleotide polymorphisms (SNPs) in the G protein subunits Galphas and Galphaq have been shown to result in altered protein expression. We now want to examine whether G Protein polymorphisms alter NYHA functional class, and hemodynamic variables in patients with coronary artery disease scheduled for coronary artery bypass grafting .

Enrollment

500 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • clinical diagnosis of coronary artery disease
  • patients scheduled for coronary artery bypass grafting

Exclusion criteria

  • emergency operation
  • combined vitium

Trial contacts and locations

1

Loading...

Central trial contact

Ulrich H Frey, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems